Rafael Holdings, Inc. RFL

Company Overview

Rafael Holdings, Inc. is a diversified holding company operating across life sciences, pharmaceuticals, real estate, and technology-enabled health research. The company’s core strategy is to own and allocate capital to a portfolio of operating businesses and assets, rather than conduct material operating activities directly. Rafael Holdings is publicly traded on the NYSE under the ticker RFL and is controlled by the Jonas family through super-voting shares.

The company’s primary value drivers are its majority ownership interest in Rafael Pharmaceuticals, Inc., ownership of clinical-stage and research-focused life science subsidiaries, and a commercial real estate portfolio primarily located in New Jersey. Rafael Holdings was formed in 2017 following a corporate reorganization and IPO, evolving from assets previously held within IDT Corporation. Its strategic positioning centers on long-duration investments in drug development and biomedical innovation, supported by stable real estate income and a strong balance sheet.